Literature DB >> 34272413

Multi-view convolutional neural networks for automated ocular structure and tumor segmentation in retinoblastoma.

Victor I J Strijbis1,2, Christiaan M de Bloeme3, Robin W Jansen3, Hamza Kebiri4,5, Huu-Giao Nguyen4, Marcus C de Jong3, Annette C Moll6, Merixtell Bach-Cuadra4,5, Pim de Graaf3, Martijn D Steenwijk7.   

Abstract

In retinoblastoma, accurate segmentation of ocular structure and tumor tissue is important when working towards personalized treatment. This retrospective study serves to evaluate the performance of multi-view convolutional neural networks (MV-CNNs) for automated eye and tumor segmentation on MRI in retinoblastoma patients. Forty retinoblastoma and 20 healthy-eyes from 30 patients were included in a train/test (N = 29 retinoblastoma-, 17 healthy-eyes) and independent validation (N = 11 retinoblastoma-, 3 healthy-eyes) set. Imaging was done using 3.0 T Fast Imaging Employing Steady-state Acquisition (FIESTA), T2-weighted and contrast-enhanced T1-weighted sequences. Sclera, vitreous humour, lens, retinal detachment and tumor were manually delineated on FIESTA images to serve as a reference standard. Volumetric and spatial performance were assessed by calculating intra-class correlation (ICC) and dice similarity coefficient (DSC). Additionally, the effects of multi-scale, sequences and data augmentation were explored. Optimal performance was obtained by using a three-level pyramid MV-CNN with FIESTA, T2 and T1c sequences and data augmentation. Eye and tumor volumetric ICC were 0.997 and 0.996, respectively. Median [Interquartile range] DSC for eye, sclera, vitreous, lens, retinal detachment and tumor were 0.965 [0.950-0.975], 0.847 [0.782-0.893], 0.975 [0.930-0.986], 0.909 [0.847-0.951], 0.828 [0.458-0.962] and 0.914 [0.852-0.958], respectively. MV-CNN can be used to obtain accurate ocular structure and tumor segmentations in retinoblastoma.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34272413     DOI: 10.1038/s41598-021-93905-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  4 in total

1.  Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.

Authors:  Roland M Martens; Daniel P Noij; Thomas Koopman; Ben Zwezerijnen; Martijn Heymans; Marcus C de Jong; Otto S Hoekstra; Marije R Vergeer; Remco de Bree; C René Leemans; Pim de Graaf; Ronald Boellaard; Jonas A Castelijns
Journal:  Eur J Radiol       Date:  2019-02-04       Impact factor: 3.528

2.  Statistical modeling of the eye for multimodal treatment planning for external beam radiation therapy of intraocular tumors.

Authors:  Michael B Rüegsegger; Meritxell Bach Cuadra; Alessia Pica; Christoph A Amstutz; Tobias Rudolph; Daniel Aebersold; Jens H Kowal
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-08-04       Impact factor: 7.038

3.  Value of MR-based radiomics in differentiating uveal melanoma from other intraocular masses in adults.

Authors:  Yaping Su; Xiaolin Xu; Panli Zuo; Yuwei Xia; Xiaoxia Qu; Qinghua Chen; Jian Guo; Wenbin Wei; Junfang Xian
Journal:  Eur J Radiol       Date:  2020-09-08       Impact factor: 3.528

4.  Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.

Authors:  Steven W Mes; Floris H P van Velden; Boris Peltenburg; Carel F W Peeters; Dennis E Te Beest; Mark A van de Wiel; Joost Mekke; Doriene C Mulder; Roland M Martens; Jonas A Castelijns; Frank A Pameijer; Remco de Bree; Ronald Boellaard; C René Leemans; Ruud H Brakenhoff; Pim de Graaf
Journal:  Eur Radiol       Date:  2020-06-04       Impact factor: 5.315

  4 in total
  1 in total

1.  MRI-based 3D retinal shape determination.

Authors:  Luc van Vught; Denis P Shamonin; Gregorius P M Luyten; Berend C Stoel; Jan-Willem M Beenakker
Journal:  BMJ Open Ophthalmol       Date:  2021-11-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.